Trial
NCT04632199
Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Ipsen
Collaborators
—
Condition
Pancreatic Ductal Adenocarcinoma
Intervention
111In-IPN01087 Low dose
Why stopped
Business decision not related to any safety or tolerability concern
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-24